Preprint
Nintedanib, Pirfenidone and Pirfenidone Versus Nintedanib: A Systematic Review And Meta-Analysis
Abstract
Background: Patients with idiopathic pulmonary fibrosis have a poor overall prognosis. Only nintedanib and pirfenidone have been shown to reduce mortality.
Objective: This systematic review and meta-analysis aims to assess the efficacy of nintedanib, pirfenidone, and pirfenidone vs nintedanib on patient important outcomes.
Authors
Pitre T; Husnudinov R; Khalid MF; Zhang MC; Cui S; Tran J; Mah J; Helmeczi W; Su J; Jones A
DOI
10.21203/rs.3.rs-589439/v1
Preprint server
Research Square